KindlyMD, a healthcare data and technology company based in Salt Lake City, Utah, is set to raise $250 million through a secured convertible note offering in collaboration with Antalpha, a Nasdaq-listed firm. This strategic move is part of a broader effort by KindlyMD to expand its Bitcoin treasury and strengthen its long-term financial position. The deal is being executed through KindlyMD’s treasury arm, Nakamoto Holdings, which currently holds approximately $726 million in Bitcoin assets.
The partnership with Antalpha—another public company with a strong presence in the cryptocurrency finance space—marks a significant step in KindlyMD’s transition from a traditional healthcare data firm to a Bitcoin-focused financial entity. This pivot began in earnest after its merger earlier this year with Nakamoto Holdings, a company originally spearheaded by Bitcoin Magazine CEO David Bailey.
According to the announcement, the five-year convertible note will serve multiple purposes. Primarily, it offers a form of long-term financing that reduces the dilution risk typically associated with convertible debt instruments, which often convert to equity at a discount. The funds raised through the issuance will also be allocated for general corporate initiatives and to further bolster the company’s Bitcoin reserves.
David Bailey, who now serves as Chairman and CEO of KindlyMD following the merger, emphasized the significance of the partnership. “This collaboration underscores the strength of Bitcoin-native companies supporting one another,” he said. “With Antalpha, we’re not just addressing immediate capital needs—we’re reinforcing the long-term financial infrastructure of the Bitcoin ecosystem.”
Convertible debt is an increasingly popular tool among crypto-aligned firms, offering flexible capital without immediately impacting shareholder equity. In KindlyMD’s case, the structure of the secured note suggests a cautious yet ambitious approach to capital management. By tying the debt to its Bitcoin treasury unit, the company effectively backs the loan with its crypto holdings, potentially reducing investor risk while maintaining strategic liquidity.
Antalpha’s involvement further validates the credibility of the transaction. As a Nasdaq-listed company with a focus on digital asset investments and infrastructure, Antalpha brings institutional weight to the deal. Their participation signals broader market confidence in Bitcoin-backed financing models, despite ongoing regulatory scrutiny and market volatility.
KindlyMD’s aggressive accumulation of Bitcoin aligns with a growing trend among U.S. corporations seeking financial diversification through digital assets. MicroStrategy and Tesla are among the most notable examples, but the entry of a healthcare-turned-Bitcoin firm like KindlyMD showcases how diverse industries are adopting crypto strategies for treasury management.
This $250 million convertible note could also pave the way for additional institutional interest in crypto-backed financial instruments. By demonstrating a viable model for secured, Bitcoin-backed debt, KindlyMD and Antalpha are helping to bridge traditional capital markets with decentralized finance frameworks.
In addition to boosting its Bitcoin holdings, KindlyMD may also be positioning itself for potential future integrations of blockchain technology into its core healthcare data services. While no official announcement has been made in that regard, the company’s pivot toward crypto finance opens doors for innovation in data security, interoperability, and patient privacy—areas where blockchain offers transformative potential.
Moreover, the move comes at a time when Bitcoin is regaining momentum in the market, trading near multi-month highs. This timing could prove advantageous for KindlyMD, allowing it to capitalize on rising asset values while securing low-dilution financing.
The five-year term of the convertible note also suggests that KindlyMD is taking a long-term view on Bitcoin’s growth. Rather than pursuing short-term gains, the company appears to be building a financial foundation that anticipates broader adoption of BTC as a reserve asset.
Looking ahead, the success of this initiative could inspire similar strategies among mid-sized firms seeking alternative ways to raise capital without resorting to traditional equity dilution or high-interest debt. It may also push more Nasdaq-listed companies to explore Bitcoin-backed financial instruments as a legitimate asset class.
Finally, the deal reflects a broader shift in how companies view Bitcoin—not merely as a speculative asset, but as a strategic treasury reserve tool that can underpin complex financial products. If market conditions remain favorable, KindlyMD’s model could become a blueprint for future corporate engagement with cryptocurrency at scale.